Category Archives: Poor Research

Recent in: Poor Research

Antibiotic Prophylaxis for Lyme Disease: How the Way of Reporting a Clinical Trial Can Alter the Perception of Effectiveness

Urba`Gonza´ lez, MD, PhD; Department of Dermatology, Clinica Plato´ , Barcelona, Spain “Comment I recommend the complementary reading of other commentaries about the applicability of this study. Shapiro, in an accompanying editorial,1 pointed out the difficulty in clinical practice to know the species, stage, degree of engorgement of the tick, and even the difficulty to determine if the “tick” is Continues →

Lyme Misdiagnosis Can Divert Patients From Correct Treatment

[CanLyme Note: We agree totally that a thorough diagnostic work-up should preclude any diagnosis.  Not everything is Lyme borreliosis.  What is so dismaying, however, is the focus of the US CDC MD’s on the few cases such as those listed in this article, while they ignore the tens of thousands of legitimate chronic Lyme disease cases. We in Canada are already Continues →

Why is the CDC Trying to Block an Accurate Lyme Disease Test?

Posted on January 16, 2014 By Bob Goodwin, an investor and medical device entrepreneur who lives in Mercer Island, Washington A recent article in Medscape is titled New Lyme Culture Test Failed CDC Analysis. At first I took the article and paper at face value, and tried to dig into the errors of a chronic-Lyme disease researcher. The only errors Continues →

More on Who’s Who and What’s What – NIH Dr. Phil Baker Responds to Blog on American Lyme Disease Foundation

LYMEPOLICYWONK:  Last week, I posted a blog regarding the IDSA stealth front organization, the American Lyme Disease Foundation (ALDF).  I pointed out that the organization masquerades as a patient organization or an independent source of information, but is really just the members of the IDSA Lyme guidelines panel and a couple of businessmen. I highlighted the fact that Dr. Phil Continues →

The Klempner Article

The recent article in the NEJM, “Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease,” by Klempner, et. al., provides some interesting data, but the proper interpretation of this data is of little relevance to both clinical practice and guidelines related to chronic Lyme disease.